The UCSF Helen Diller Family Comprehensive Cancer Center supports innovative cancer research through two intramural award programs:
American Cancer Society Institutional Research Award
The purpose of the American Cancer Society Institutional Research Award is to make available seed funding for junior investigators to initiate promising new projects in cancer-related research that may enable them to compete successfully for national research grants. Funding for this program is supported by a grant from the American Cancer Society.

Clinical Investigator Research Program
The Clinical Investigator Research Program provides seed funding to encourage clinical investigators, especially those at the beginning of their career, to initiate promising projects that may enable them to compete successfully for national research grants. Targeted areas are innovative pilot and phase I/II studies and other projects in clinical, health policy, health services, and psychosocial and behavioral research. The review process for this award is consolidated with other pilot-funding mechanisms through the Resource Allocation Program. See the RAP website for additional information.
| Summary Criteria, CC Intramural Awards Program | ||
|
American Cancer Society Institutional Research Award |
Clinical Investigator Research Program | |
| Amounts | Awards up to $30,000 | Awards up to $75,000/yr for 2 yrs |
| Deadline | Fall 2013 | Call for applications in August. |
| Eligibility | Young investigators within first 6 years of faculty appointment | All clinically based MD or MD/PhD Cancer Center members |
| For Clinical Research? |
Yes |
Yes—clinical and translational research |
| Are Postdocs Eligible? |
No |
No |
| Are Current National Grants OK? |
No |
Yes |